"Das Thoraxzentrum Bezirk Unterfranken ist eine spezialisierte Lungenfachklinik mit folgenden Bereichen: Pneumologie, Thoraxchirurgie, pneumologische Onkologie, Tuberkulose und Schlafmedizin. Wir verfügen über eine große, über fünfzigjährige Erfahrung bei der Behandlung von Erkrankungen der Lunge, des Mediastinums, des Zwerchfells, der Brustwand und des Pleuraraumes. Dies macht uns in Unterfranken einmalig. Im Vordergrund unserer ärztlichen und pflegerischen Behandlung steht als Ziel eine optimale, auf dem modernsten Stand der Wissenschaft beruhende Versorgung unserer Patienten unter Berücksichtigung der medizinischen und psychosozialen Aspekte."

During the past decade, Thoraxzentrum Bezirk Unterfranken conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thoraxzentrum Bezirk Unterfranken" #1 collaborator was "German Research Foundation" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Thoraxzentrum Bezirk Unterfranken" are "Pulmonary Disease, Chronic Obstructive" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Extensive-stage Small Cell Lung Cancer" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Thoraxzentrum Bezirk Unterfranken" in a lesser frequency.

Most popular intervention types in "Thoraxzentrum Bezirk Unterfranken" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist" (1 trials), "PRM-151 (Zinpentraxin Alfa)" (1 trials), "Placebo" (1 trials) and "Spiolto® Respimat®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thoraxzentrum Bezirk Unterfranken" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Thoraxzentrum Bezirk Unterfranken". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Thoraxzentrum Bezirk Unterfranken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thoraxzentrum Bezirk Unterfranken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".